未登录 分享 收藏
Determinants of delayed postoperative radiation therapy in breast cancer patients undergoing neoadjuvant chemotherapy: A subanalysis of the AMAZONA III prospective cohort 乳腺癌患者接受新辅助化疗后延迟术后放疗的决定因素：AMAZONA III前瞻性队列研究的亚组分析 Prestes, Julio Cesar; Viani, Gustavo; Gouveia, Andre Guimaraes; Silva, Mauricio Fraga Da; Moraes, Fabio Ynoe.; Rosa, Daniela Dornelles; Barrios, Carlos Henrique Escosteguy; Werutsky, Gustavo; Bines, Jose; Silva, Eduardo Henrique Cronemberger Costa E.; Queiroz, Geraldo Silva; Makdissi, Fabiana Baroni; Lima, Vladmir Cordeiro De; Freitas-Junior, Ruffo; Filho, Jose D'oliveira Couto; Emerenciano, Karla; Resende, Heloisa Magda; Crocamo, Susanne; Reinert, Tomas; Van Eyll, Brigitte; Neron, Yeni Veronica; Dybal, Vanessa; Lazaretti, Nicolas Silva; Costamilan, Rita De Cassia; Andrade, Diocesio Alves Pinto De; Mathias, Clarissa; Vacaro, Giovana Zerwes; Borges, Giuliano; Filho, Carlos Alberto Sampaio Pereira; Mano, Max Senna; Simon, Sergio Daniel; Jesus, Rafaela Gomes De; Cabalheiro, Taina; Rebelatto, Taiane Francieli; Marta, Gustavo Nader 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer Cortes, Javier; Punie, Kevin; Barrios, Carlos; Hurvitz, Sara A.; Schneeweiss, Andreas; Sohn, Joohyuk; Tokunaga, Eriko; Brufsky, Adam; Park, Yeon Hee; Xu, Binghe; Hegg, Roberto; Oliveira, Mafalda; Fabi, Alessandra; Vaksman, Natalya; Valdez, Theresa; Zhang, Xinrui; Lai, Catherine; Tolaney, Sara M. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Germline Genetic Testing in Breast Cancer: Utilization and Disparities in a Middle-Income Country de Souza, Alessandra Borba Anton; Barrios, Carlos; de Jesus, Rafaela Gomes; Reinert, Tomas; Giacomazzi, Juliana; Rosa, Daniela D.; Cronemberger, Eduardo; Werutsky, Gustavo; Bines, Jose; Queiroz, Geraldo Silva; de Lima, Vladmir Cordeiro; Freitas-Junior, Ruffo; Couto Filho, Jose d'Oliveira; Emerenciano, Karla; Resende, Heloisa; Crocamo, Susanne; Van Eyll, Brigitte; Neron, Yeni; Dybal, Vanessa; Lazaretti, Nicolas Silva; Costamilan, Rita de Cassia; de Andrade, Diocesio Alves Pinto; Mathias, Clarissa; Vacaro, Giovana Zerwes; Borges, Giuliano; Morelle, Alessandra Menezes; Sampaio Filho, Carlos Alberto; Mano, Max; Lichtenfels, Martina; Simon, Sergio D.; Fay, Andre P. 分享 收藏
Prognostic variables for risk of recurrence in patients (pts) with HR+/HER2-early breast cancer (EBC) using data from the NATALEE trial: a machine learning (ML) model-based analysis HR+/HER2-早期乳腺癌（EBC）患者复发风险的预后变量：基于NATALEE试验数据的机器学习（ML）模型分析 Fasching, P. A.; Barrios, C. H.; Lim, E.; Graff, S. L.; Chia, S.; Frenel, J. -s.; Im, S. -a.; Huang, C. -s.; Ring, A.; Nowecki, Z.; Liu, Q.; Akdere, M.; Zarate, J. P.; Hu, H.; Pantoja, K.; O'Shaughnessy, J. A. 分享 收藏
Nivolumab plus ipilimumab versus sunitinib for fi rst-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial Nivolumab联合ipilimumab与舒尼替尼用于晚期肾细胞癌的一线治疗: CheckMate 214 III期试验的疗效和安全性的8年随访结果 Tannir, N. M.; Albiges, L.; Mcdermott, D. F.; Burotto, M.; Choueiri, T. K.; Hammers, H. J.; Barthelemy, P.; Plimack, E. R.; Portat, C.; George, S.; Donskov, F.; Atkins, M. B.; Gurney, H.; Kollmannsberger, C. K.; Grimm, M. -o.; Barrios, C.; Tomita, Y.; Castellano, D.; Gruenwald, V.; Rini, B. I.; Jiang, R.; Desilva, H.; Fedorov, V.; Lee, C. -w.; Motzer, R. J. 分享 收藏
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7) 6th和7th晚期乳腺癌管理国际共识指南 (ABC指南6和7) Cardoso, Fatima; Paluch-Shimon, Shani; Schumacher-Wulf, Eva; Matos, Leonor; Gelmon, Karen; Aapro, Matti S.; Bajpai, Jyoti; Barrios, Carlos H.; Bergh, Jonas; Bergsten-Nordstrom, Elizabeth; Biganzoli, Laura; Cardoso, Maria Joao; Carey, Lisa A.; Chavez-MacGregor, Mariana; Chidebe, Runcie; Cortes, Javier; Curigliano, Giuseppe; Dent, Rebecca A.; El Saghir, Nagi S.; Eniu, Alexandru; Fallowfield, Lesley; Francis, Prudence A.; Millan, Sandra X. Franco; Gilchrist, Jenny; Gligorov, Joseph; Gradishar, William J.; Haidinger, Renate; Harbeck, Nadia; Hu, Xichun; Kaur, Ranjit; Kiely, Belinda; Kim, Sung-Bae; Koppikar, Smruti; Kuper-Hommel, Marion J. J.; Lecouvet, Frederic E.; Mason, Ginny; Mertz, Shirley A.; Mueller, Volkmar; Myerson, Claire; Neciosup, Silvia; Offersen, Birgitte, V; Ohno, Shinji; Pagani, Olivia; Partridge, Ann H.; Penault-Llorca, Frederique; Prat, Aleix; Rugo, Hope S.; Senkus, Elzbieta; Sledge, George W.; Swain, Sandra M.; Thomssen, Christoph; Vorobiof, Daniel A.; Vuylsteke, Peter; Wiseman, Theresa; Xu, Binghe; Costa, Alberto; Norton, Larry; Winer, Eric P. 分享 收藏
The somatic mutation profile of estrogen receptor-positive HER2-negative metastatic breast cancer in Brazilian patients Reinert, Tomas; do Rego, Fernanda Orpinelli; Silva, Matheus Costa e; Rodrigues, Amanda Muniz; Koyama, Fernanda Christtanini; Goncalves, Aline Coelho; Pauletto, Maiane Maria; de Carvalho Oliveira, Leandro Jonata; de Resende, Cristiano Augusto Andrade; Landeiro, Luciana Castro Garcia; Barrios, Carlos Henrique; Mano, Max Senna; Dienstmann, Rodrigo 分享 收藏
Ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI) as adjuvant treatment in patients with HR+/HER2-early breast cancer: final invasive disease-free survival (iDFS) analysis from the NATALEE trial Hortobagyi, Gabriel; Stroyakovsky, Daniil; Yardley, Denise; Huang, Chiun-Shen; Fasching, Peter A.; Crown, John; Bardia, Aditya; Chia, Stephen; Im, Seock-Ah; Martin, Miguel; Loi, Sherene; Xu, Binghe; Hurvitz, Sara; Barrios, Carlos; Untch, Michael; Moroose, Rebecca; Visco, Frances; Parnizari, Federico; Ghaznawi, Farhat; Li, Zheng; Waters, Sorcha; Chakravartty, Arunava; Slamon, Dennis 分享 收藏
ASCENT-07: A phase 3, randomized, open-label study of sacituzumab govitecan versus treatment of physician's choice in patients with HR+/HER2-inoperable, locally advanced, or metastatic breast cancer post-endocrine therapy Rugo, Hope; Cortes, Javier; Curigliano, Giuseppe; Barrios, Carlos; Punie, Kevin; Park, Yeon; Iwata, Hiroji; Young, Alex; Ren, Xuehan; Cinar, Pelin; Jhaveri, Komal 分享 收藏
Safety evaluation from the KEYNOTE-355 study of pembrolizumab plus chemotherapy vs placebo plus chemotherapy in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer Rugo, Hope; Schmid, Peter; Nowecki, Zbigniew; Cescon, David; Im, Seock-Ah; Yusof, Mastura; Gallardo, Carlos; Iwata, Hiroji; Barrios, Carlos; Loi, Sherene; Zhou, Xuan; Zhang, Xiaoli; Pan, Wilbur; Karantza, Vassiliki; Cortes, Javier 分享 收藏
INAVO121: Phase III study of inavolisib plus fulvestrant vs alpelisib plus fulvestrant in patients with hormone receptorpositive, HER2-negative, PIK3CAmutated locally advanced or metastatic breast cancer Juric, Dejan; Kalinsky, Kevin; Im, Seock-Ah; Ciruelos, Eva; Bianchini, Giampaolo; Barrios, Carlos; Jacot, William; Schmid, Peter; Loi, Sherene; Rugo, Hope; Craine, Veronica; Hutchinson, Katherine; Flechais, Aulde; Thanopoulou, Eirini; Harbeck, Nadia 分享 收藏
Safety evaluation from the KEYNOTE-522 study of neoadjuvant pembrolizumab (or placebo) plus chemotherapy followed by adjuvant pembrolizumab (or placebo) in patients with early triple-negative breast cancer (TNBC) Cortes, Javier; Dent, Rebecca; Pusztai, Lajos; McArthur, Heather; Kuemmel, Sherko; Denkert, Carsten; Park, Yeon Hee; Hui, Rina; Takahashi, Masato; Barrios, Carlos; Zhu, Yalin; Zhang, Xiaoli; Pan, Wilbur; Karantza, Vassiliki; O'Shaughnessy, Joyce; Schmid, Peter 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
Annals of Oncology.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏